The mechanism of action of Lithium are mediated via Lithium ions that influence multiple neurotransmission process. It influences both the adenylyl cyclase & phospholipase C protein couples messenger systems. Influences IP3 & DAG and Camp 2ND messengers by decreasing the various enzymes which are important for the conversion and the re-circulation of membrane phosphoinositides. IP3 and DAG are important in monoamine and cholinergic transmission.
What is the therapeutic index of lithium and what is its clinical significance?
Very small therapeutic index (0.5-1.5 Mm) to produce therapeutic benefits in this range. This implies that plasma monitoring is very important as if the values are below 0.5 then there will be sub therapeutic effects and pharmacological treatment is not effective. If ranges of above 2 Mm are reached then toxicity occurs and leads to various adverse effects and which are dangerous and potentially harmful
Monotherapy for bipolar disorder and acute manic episodes lithium is indicated.
In rapid cycling lithium can be considered as monotherapy
Combination therapy: lithium and antidepressants for severe depressant episodes and initial treatment with SSRI can cause manic episode this reduces the occurrence.
Lithium and valproate when there is no or partial response to monotherapy
Acute toxicity: GI disturbances including nausea, vomiting and diarrhoea
Neurological toxicity: tremor, sedation, ataxia, muscle weakness, fatigue, polydipsia, polyuria, nocturia, nephrotic diabetes insipidus, thyroid enlargement, leucocytosis, edema, weight gain, acne, alopecia, sexual dysfunction
Cautionary use in pregnancy, should not be used especially during the first semester. It crosses the placental barrier which can cause the foetus to show lethargy and flaccid muscle tone. Contraindicated during breastfeeding as it is secreted in breast milk
Depression, schizophrenia and mania
Ms B. Polar (21 years, 60 kg) is a student and used the following medication for the past two months:
Camcolith 600mg bd. The plasma levels after two weeks were 0.8mmol/l. She sustained a muscle injury and has been using Indocid® 75mg nocte for the past 10 days NSAID. On questioning she reveals that “she had picked up a lot of weight” and is now using some of her mother’s “water pills” in the hope of losing a few of the extra kilos. However, she complains of fatigue, that she has difficulty in keeping her eyes open in class, remains thirsty and constantly feels shaky and nauseous
The indocid (NSAID) % diuretic she has been using are increasing her lithium plasma levels which are contributing to the side effects experienced such as the weight gain, fatigue, nausea, shakiness and polydipsia and muscle injury. Especially because within the first 2 weeks she already reached 0.8mmol/l the half-life can lead to accumulation when administered with NSAIDs & diuretics.
The recommendation I would make would be to stop using the NSAID as well as the ‘water pills” immediately and then to check and monitor her plasma levels weekly until a stable plasma level is obtained. Her symptoms have to be monitored when she is not on any concurrent treatment that can affect her lithium levels to establish if a lower dosage will reduce some of her symptoms.
As B Polar is still very young and of child bearing potential I would recommend to switch her to an alternative treatment now like Lamotrogine since this is also safe in pregnancy if she chooses to want children in the near future especially since lithium is not recommend during pregnancy and breastfeeding. Regarding her weight gain that clearly is bothering her I would recommend healthy eating plan and more frequent exercise to start with and then later additional therapy if required.
Brand, L.Prof. 2021. Study Unit 9:Anti-psychotic Drugs and Lithium. Unpublished lecture notes on efundi, FKLG 312. Potchefstroom: NWU. [PowerPoint presentation]